Parental attitudes and opinions on the use of psychotropic medication in mental disorders of childhood

Annals of General Psychiatry

Volumn 6, Issue , 2007, Pages

  Lazaratou, Helen ^a   Anagnostopoulos, Dimitris C ^a   Alevizos, Elias V ^b   Haviara, Fotini ^a   Ploumpidis, Dimitris N ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; METHYLPHENIDATE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CHI SQUARE TEST; CHILD; CHILDHOOD; CONTROLLED STUDY; DEMOGRAPHY; DRUG CLASSIFICATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; EDUCATION; FEMALE; FISHER EXACT TEST; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTHER; OUTPATIENT CARE; PARENTAL ATTITUDE; PATIENT COMPLIANCE; PSYCHIATRIST; PSYCHOTHERAPY; QUESTIONNAIRE; SCHIZOPHRENIA; SOCIAL ASPECT;

EID: 38349154932     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-6-32     Document Type: Article

References (32)

1. Massari B Prescription of psychotropic drugs in child psychiatry Neuropsychiat Enfance Adolesc 1984, 32:433-441
2. Shapiro T Developmental considerations in psychopharmacology: The interaction of drugs and development Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders New York: Wiley Wiener J 1996, 79-95
3. Simeon J Challenges to pediatric psychopharmacology J Psychiat Neuroscience 1997, 22:15-17
4. Vitiello B Jensen PS Medication development and testing in children and adolescents: Current problems, future directions Arch Gen Psychiatry 1997, 54:871-876 9294379
5. Tsiantis J The challenges of child psychiatry in the rising of new millennium [in Greek] Paediatriki 2000, 63:186-190
6. Lyons JS Maclntyre JC Lee ME Carpinello S Zuber MP Fazio ML Psychotrpic medication prescribing patterns for children and adolescents in New York's public mental health system Community Ment Health J 2004, 40:101-118 10.1023/B:COMH.0000022731.65054.3e 15206636
7. Cooper WO Hickson GB Fuchs C Arbogast PG Ray WA New users of antipsychotic medications among children enrolled in TennCare Arch Pediatr Adolesc Med 2004, 158:753-759 10.1001/archpedi.158.8.753 15289247
8. Staller J Wade M Baker M Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York J Child Adolesc Psychopharmacol 2005, 15:57-61 10.1089/cap.2005.15.57 15741786
9. Patel NC Sanchez RJ Johnsrud MT Crimson Ml Trends in antipsychotic use in a Texas Medicaid population of children and adolescents J Child Adolesc Psychopharmacol 2002, 12:221-229 10.1089/104454602760386905 12427295
10. Connor DF Ozbayrak KR Harrison RJ Melloni RH Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment J Child Adolesc Psychopharmacol 1998, 8:27-38 9639077
11. Duffy FF Narrow WE Rae DS West JC Zarin DA Rubio-Stipec M Pincus HA Regier DA Concomitant pharmacotherapy among youths treated in routine psychiatric practice J Child Adolesc Psychopharmacol 2005, 15:12-25 10.1089/cap.2005.15.12 15741782
12. dos Reis S Zito J Safer DJ Gardner GF Puccia KB Owens PL Multiple psychotropic medication use for youths: A two-state comparison J Child Adolesc Psychopharmacol 2005, 15:68-77 10.1089/cap.2005.15.68 15741788
13. Simeon JG Wiggins DM Williams E World wide use of psychotropic drugs in child and adolescent psychiatric disorders Progr Neuro Psychopharmacol Biol Psychiatry 1995, 19:455-465 10.1016/0278-5846(95)00026-R
14. McLeod JD Pescosolido BA Takeuchi DT White TF Public attitudes toward the use of psychiatric medications for children J Health Soc Behav 2004, 45:53-67 15179907
15. Hatzimanolis I Alevizos V Attitudes and opinion of non-psychiatric physicians and a general population sample about psychotropic drugs [in Greek] Psychiatry 1999, 10:135-141
16. World Health Organisation The ICD-10 Classification of Mental and Behavioural Disordres: Clinical Descriptions and Diagnostic Guidelines Geneva: WHO 1992
17. Schnittker J Misgivings of medicine? African Americans' skepticism of psychiatric medication J Health Soc Behav 2003, 44:506-524 10.2307/ 1519796 15038146
18. Raghavan R Zima BT Andersen RM Leibowitz AA Schuster MA Landsverk J Psychotropic medication use in a national probability sample of children in the child welfare system J Child Adolesc Psychopharmacol 2005, 15:97-106 10.1089/cap.2005.15.97 15741791
19. Pappaport N Chubinsky P The meaning of psychotropic medication for children, adolescents, and their families J Am Acad Child Adolesc Psychiatry 2000, 39:1198-1200 10.1097/00004583-200009000-00021 10986818
20. Hack S Chow B Pediatric psychotropic medication compliance: A literature review and research-based suggestions for improving treatment compliance J. Child Adolesc Psychopharmacol 2001, 11:59-65 10.1089/ 104454601750143465 11322747
21. Barkley RA Fischer M Smallish L Fletcher K Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study Pediatrics 2003, 111:97-109 10.1542/peds.111.1.97 12509561
22. Wilens TE Faraone SV Biederman J Gunawardene S Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature Pediatrics 2003, 111:179-185 10.1542/peds.111.1.179 12509574
23. Biederman J Wilens T Mick E Spencer T Faraone SV Pharmacotherapy of attention-deficit hyperactivity disorder reduces the risk for substance abuse disorder Pediatrics 1999, 104:293-294 10.1542/peds.104.2.e20
24. Dosreis S Zito JM Safer DJ Soeken KL Mitchell JW Jr Ellwood LC Parental perception and satisfaction with stimulation medication for attention-deficit hyperactivity disorder J Dev Behav Pediatr 2003, 24:155-62 12806227
25. Campbell M Rapoport JL Simpson GM Antipsychotics in children and adolescents J Am Acad Child Adolesc Psychiatry 1999, 38:537-545 10.1097/ 00004583-199905000-00015 10230185
26. de Haan L Welborn K Krikke M Linszen DH Opinion of mothers on the first psychotic episode and the start of treatment of their child Eur Psychiatry 2004, 19:226-229 10.1016/j.eurpsy.2003.09.010 15196605
27. Singh I Boys will be boys: Fathers' persectives on ADHD symptoms, diagnosis and drug treatment Harvard Rev Psychiatry 2003, 6:308-316 10.1080/714044393
28. Epstein MH Singh NN Luebke J Stout CE Psychopharmacological intervention. II: Teacher perception of psychotropic medication for students with learning disabilities J Learn Disabil 1991, 24:477-483 1940604
29. Croghan TW Tomlin M Perscosolido BA Schnittker J Martin J Ludell K Swindle R American attitudes toward and willingness to use psychiatric medications J Nerv Ment Dis 2003, 191:166-174 10.1097/ 00005053-200303000-00005 12637843
30. Makoul G Arntson P Schofield T Health promotion in primary care: physician-patient communication and decision making about prescription medications Soc Sci Med 1995, 41:1241-1254 10.1016/0277-9536(95)00061-B 8545677
31. Ziegler DK Mosier MC Buenaver M Okuyemi K How much information about adverse effects of medication do patients want from physicians? Arch Intern Med 2001, 161:2387-2392 10.1001/archinte.161.5.706 11606163
32. Counsel AM Geddis DC Smith AR Parental perceptions of information about medication prescribed for their children NZ Med J 1993, 106:205-206